Syndrome group | Chi-square | Post hoc < .01 | |||||||
---|---|---|---|---|---|---|---|---|---|
PMS | ASD | FraX | DS | df | χ 2 | p value | |||
N | 30 | 30 | 30 | 30 | |||||
Agea | Mean (SD) | 10.55 (7.08) | 10.60 (7.46) | 11.37 (7.02) | 10.67 (7.00) | 3 | 1.29* | .732 | – |
Range | 4.00–37.00 | 4.00–39.00 | 6.00–39.00 | 4.00–36.00 | |||||
Gender | Male (%) | 13 (43.33) | 26 (86.67) | 30 (100.00) | 14 (46.67) | 3 | 34.19 | < .01 | ASD, FraX > PMS, DS |
Self-helpb | Mean (SD) | 4.77 (1.14) | 5.33 (1.24) | 5.33 (1.09) | 6.20 (1.06) | 3 | 20.47* | < .001 | DS > PMS, ASD, FraX |
Mobilityb | Fully mobile (%) | 22 (73.33) | 23 (76.67) | 20 (66.67) | 26 (86.67) | 3 | 34.10 | .33 | – |
Visionb | Normal (%) | 24 (80.00) | 27 (90.0) | 24 (80.0) | 19 (63.33) | 3 | 6.89 | .08 | – |
Hearingb | Normal (%) | 26 (86.67) | 27 (90.00) | 29 (96.67) | 18 (60.00) | 3 | 15.23** | .001 | PMS, ASD, FraX > DS |
Speechc | Verbal (%) | 5 (16.77) | 20 (66.77) | 24 (80.00) | 24 (80.00) | 3 | 33.96 | < .001 | ASD, DS, FraX > PMS |